Mantis Biotech is making ‘digital twins’ of humans to help solve medicine’s data availability problem

Mantis Biotech is at the forefront of creating 'digital twins' of humans, aiming to tackle significant challenges in medical data availability and enhance treatment outcomes. By integrating diverse data sources, these physics-based predictive models simulate human anatomy, physiology, and behavior, potentially revolutionizing medical research, training, and preventative healthcare. The technology is particularly beneficial in fields where data is scarce, such as rare diseases, and can provide insights into individual health conditions and athletic performance. However, the reliance on AI and large datasets raises ethical concerns regarding data privacy, potential biases, and the implications of using synthetic data in healthcare. Mantis' founder, Georgia Witchel, emphasizes the need for a shift in mindset towards testing virtual humans while respecting individuals' data rights. The recent $7.4 million seed funding from Decibel VC and Y Combinator will support the platform's growth, but it also highlights the importance of careful oversight and ethical considerations in deploying AI technologies in both sports and healthcare sectors.

Why This Matters

This article highlights the innovative approach of using digital twins to tackle data scarcity in healthcare, a critical issue that can impact patient outcomes. Understanding these risks is vital as AI technologies increasingly influence medical practices, potentially leading to biases and ethical dilemmas. The implications of misrepresentation in AI models could affect vulnerable populations, making it essential to ensure responsible AI development and deployment in healthcare.